Reports Library Publication
Insight Consumer Healthcare Latin America Sep / Oct 2026
23rd October 2026 by CHC Insight
1. Derma New consumer need shapes activity in hair loss treatments
2. Derma Non-cores Busy year for acne remedy launches with patches a key focus
3. DB6 Mid-year 2026 LatAm CHC retail growth slows but remains above global average
4. Innovation Round-up Hypera Pharma, Momenta Farma carve out new niches
5. News Review Grupo EMS, Cimed and Adium seek international expansion
Order this report
Why buy this report?
"LatAm’s derma retail sales advanced by 5.9% during MAT Q2 2026. Subcategories that drove growth included hair loss treatments (+7.8%), as marketers scramble to position new and existing brands for hair shedding in GLP-1 users (see Market Report). The impact of GLP-1 use on consumer health categories has featured notably in Insight lately, but with good reason: its implications are impossible to ignore. Recent Nestlé research highlights the extent of uptake in Brazil, with the company now using the trend to help shape its Nutrition & Health strategy (see News Review, p33). Meanwhile, Hypera has become the first marketer to offer VMS products under the same banner as its Semavy semaglutide product (see Innovation Round-up, p30). "
Nicholas Hall